Patient Outcomes following Initiation of Medical Cannabis in Women with Chronic Pelvic Pain
CANSAGE ePoster Library. Ngan T. 09/26/19; 275269; eP-136
Dr. Tin Yan Tina Ngan
Dr. Tin Yan Tina Ngan
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Rate & Comment (0)
Objective: The aim is to evaluate the efficacy and side effects of medical cannabis for chronic pelvic pain (CPP).Methods: .Three gynecologist specialized in pelvic pain who incorporated the use of medical marijuana in their practice for analgesia participated. All patients prescribed with medical marijuana between 2012 and 2018 were identified. Only those with CPP were included. A descriptive analysis assessing patient baseline characteristics was performed. The usage of medical cannabis was recorded. Patient outcomes following initiation of medical cannabis were studied. Primary outcome was pain response; secondary outcomes were side effects and resulting patterns of opioid use. Chi-square test was used to compare association between different variables. P-value of <0.05 was considered significant. Results: A total of 135 women, with mean age of 35.4 years old, were prescribed medical cannabis. 48.2%, 60.0% and 57% tried at least one type of NSAID, opioid, or neuromodulator respectively. The route of cannabis administration was mainly cannabis oil. Change in pain was documented in 82 cases: 79 experienced improvements, and 3 reported no change. No patient had worsening of pain. Of the patients who had improvement, 39 reduced their opioids use. Side effects were reported by 9 patients— the most common being headache. No significant relationship between patient baseline characteristics and change in pain was found.Conclusion: This is the first study reporting use of medical cannabis in CPP. Medical cannabis is a safe treatment with minimal side effects that can improve CPP and reduce opioids use.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings